MALAT1 and head and neck squamous cell carcinoma: However, the expression of only three lncRNA in the plasma of HNSCC patients was significantly higher than in healthy controls (HOXA11as, LINC00964 and MALAT1) and might be used as potential circulating biomarkers for early detection [45].